Showing results (11-20 of 290) with videos related to
Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Update on epidermal growth factor receptor mutations in non-small cell lung cancerGregory J Riely, Katerina A Politi, Vincent A Miller, et al.European Journal of Cancer (Oxford, England : 1990)|September 18, 2014
Genomics-based early-phase clinical trials in oncology: recommendations from the task force on Methodology for the Development of Innovative Cancer TherapiesStephen V Liu, Vincent A Miller, Marinus W Lobbezoo, et al.Journal of Neuro-Oncology|February 11, 2010
High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancerJennifer L Clarke, William Pao, Nian Wu, et al.Seminars in Oncology|March 15, 2002
Trastuzumab in the treatment of non-small cell lung cancerChristopher G Azzoli, Lee M Krug, Vincent A Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2011
New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancerGeoffrey R Oxnard, Maria E Arcila, Juliann Chmielecki, et al.Cancer Biology & Therapy|May 20, 2014
Successful treatment of a patient with Li-Fraumeni syndrome and metastatic lung adenocarcinoma harboring synchronous EGFR L858R and ERBB2 extracellular domain S310F mutations with the pan-HER inhibitor afatinibYuxia Jia, Siraj M Ali, Shumaila Saad, et al.JCO Precision Oncology|October 5, 2020
Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment ParadigmsRamez N Eskander, Julia Elvin, Laurie Gay, et al.Cancer Chemotherapy and Pharmacology|August 17, 2004
Phase I study of green tea extract in patients with advanced lung cancerScott A Laurie, Vincent A Miller, Stefan C Grant, et al.Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbineLee M Krug, Vincent A Miller, Daniel A Filippa, et al.Seminars in Oncology|March 14, 2003
Targeting lethal minimal residual disease in small cell lung cancerJyoti D Patel, Lee M Krug, Christopher G Azzoli, et al.Pageof 29